Arcadia Biosciences RKDA Estimates

NASDAQ RKDA
$0.28 0.00 (-1.14%)
As of: Sep 30, 2026 · 2:15 PM EDT
Analyst Estimates

Arcadia Biosciences, Inc. Revenue Estimates

Periods 14
Next Period Q3 26
Consensus 2.51 M

Analysts expect Arcadia Biosciences, Inc. to report revenue of 2.51 M for Q3 26, against a range of 2.38 M to 2.63 M. The most recent reported quarter, Q2 26, came in at 1.44 M, a 19.9% miss against the 1.80 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 1.54 M1.22 M1.20 M1.46 M1.30 M901,000.001.10 M1.44 M------
High Estimate 1.47 M1.18 M1.43 M1.55 M1.95 M1.39 M1.65 M1.91 M2.63 M1.80 M1.51 M1.69 M2.88 M2.40 M
Low Estimate 1.21 M1.03 M1.34 M1.44 M1.75 M1.25 M1.35 M1.68 M2.38 M1.68 M1.40 M1.50 M2.37 M1.96 M
Consensus Estimate 1.34 M1.11 M1.38 M1.50 M1.85 M1.32 M1.50 M1.80 M2.51 M1.74 M1.45 M1.60 M2.62 M2.18 M
Analyst Estimates

Arcadia Biosciences, Inc. Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q3 26
Consensus -0.44

Analysts expect Arcadia Biosciences, Inc. to report earnings per share of -0.44 for Q3 26, against a range of -0.47 to -0.41. The most recent reported quarter, Q2 26, came in at -2.09, a 294.3% miss against the -0.53 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -1.18-2.981.90-3.26-0.85-0.97-2.11-2.09------
High Estimate -0.81-0.83-0.99-0.72-0.48-0.59-0.70-0.48-0.41-0.58-3.18-2.78-0.39-0.08
Low Estimate -0.93-1.01-1.07-0.80-0.58-0.67-0.80-0.58-0.47-0.70-3.44-3.26-0.43-0.08
Consensus Estimate -0.87-0.92-1.03-0.76-0.53-0.63-0.75-0.53-0.44-0.64-3.31-3.02-0.41-0.08

Arcadia Biosciences, Inc. Estimates API

Pull Wall Street consensus for Arcadia Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=RKDA&mode=revenue&api_key=YOUR_API_KEY